T7 mScript™ Standard mRNA Production System V2

  • All-in-one kit to produce uridine-containing, fully 5’ capped and 3’ poly(A) tailed mRNA (U-mRNA).
  • Combine the benefits of high-yield transcription with post-transcriptional capping and tailing.
  • Obtain virtually 100% 5’-capped transcripts.
  • Create variable 3’ poly(A) tail lengths, from 50 to >300 A’s.
  • Two kit sizes to produce 0.6 or 1.5 mg of U-mRNA.
  • ScriptGuard™ RNase Inhibitor included to protect synthesized mRNA from RNase degradation.

Product is for research use only (RUO)

T7 mScript™ Standard mRNA Production System V2
Catalog #
Size
Price
Quantity
Catalog #: C-MSC11610
Size: 10 reactions
Price: $356.00
Catalog #: C-MSC100625
Size: 25 reactions
Price: $780.00

Product Description:

The T7 mScript™ Standard mRNA Production System V2 provides all enzymes and reagents for making canonical uridine (U)-containing, 5'-capped and
3'-polyadenylated mRNA. The kit includes reagents for four workflow modules, (1) high-yield in vitro transcription of linear double-stranded DNA templates using the T7 mScript™ Enzyme Solution and the canonical nucleotides ATP, CTP, GTP and UTP, (2) enzymatic capping of the RNA using the ScriptCap™ Cap 1 Capping System (contains both ScriptCap™ Capping Enzyme and 2'-O-Methyltransferase) for making mRNA with a Cap 1 cap structure, (3) A-Plus™ Poly(A) Polymerase for adding a
3' poly(A) tail and (4) 5 M NH4OAc as a convenient RNA/mRNA purification method. ScriptGuard™ RNase Inhibitor is included in the kit to protect synthesized mRNA from RNase degradation.

Post-transfection, capped and tailed mRNA has increased stability and translation efficiency in most eukaryotic cell lines. The mScript™ System improves upon co-transcriptional capping and tailing methods by ensuring virtually 100% transcript capping and enabling users to define their desired tail lengths, even greater than 300 A's. In this way, poly(A) tail lengths can be generated much longer than is possible using a template-encoded tail. mRNAs with longer poly(A) tails are expressed for longer periods of time in cells. mScript™ U-mRNA is suitable for use in transfection and microinjection experiments as well as in vitro translation systems.

For reduction of immunogenicity, combine mScript™ U-mRNA with the Min-Immune™ Gold dsRNA Removal Kit to produce virtually dsRNA-free (to <0.005% of sample [LLOQ]), ultra-low immunogenicity mRNA that is suitable for downstream applications such as cell and gene therapy research and mRNA vaccine development.

CELLSCRIPT™ also offers the INCOGNITO™ T7 mScript™ N1meΨ-mRNA Production System and INCOGNITO™ T7 mScript™ Ψ-mRNA Production System to produce low immunogenicity mRNA containing the modified nucleotides N1-methyl-pseudouridine and pseudouridine, respectively.


Sample Product(x1) added to cart

Cellscript Menu